No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
High Quality Cyclical Stocks According to Morgan Stanley
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $440
IDEXX Laboratories' (NASDAQ:IDXX) Earnings Growth Rate Lags the 9.6% CAGR Delivered to Shareholders
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback?